AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $8,570,000 | +9.9% | 888,980 | +12.7% | 3.52% | +7.2% |
Q1 2021 | $7,795,000 | -74.3% | 788,980 | -40.0% | 3.29% | -69.8% |
Q4 2020 | $30,372,000 | +47.8% | 1,315,395 | -9.6% | 10.86% | +24.8% |
Q3 2020 | $20,550,000 | -9.5% | 1,455,395 | -3.3% | 8.70% | -14.0% |
Q2 2020 | $22,701,000 | +83.3% | 1,505,395 | +12.3% | 10.12% | +34.8% |
Q1 2020 | $12,385,000 | – | 1,340,395 | – | 7.51% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |